Gilion Hautvast
Papers
3
Total Citations
24
H-Index
3
About
Gilion Hautvast is a leading researcher in the field of MR-guided high-dose-rate (HDR) brachytherapy for prostate cancer, with a focused expertise in automated treatment planning and robotic needle insertion. His work centers on optimizing focal HDR brachytherapy as a less toxic alternative to whole-gland treatment, leveraging the superior soft-tissue visualization of MRI to precisely target tumors while sparing surrounding healthy tissue. Hautvast’s major contributions include developing an automated optimization tool for divergent needle patterns in focal prostate brachytherapy (cited 10 times), which enables more accurate dose delivery under MR guidance. He also pioneered a novel adaptive needle insertion sequencing method for robotic, single-needle MR-guided procedures (7 citations), addressing the spatial constraints of closed-bore MRI systems. Additionally, his simulation study on adaptive planning strategies to mitigate needle positioning errors (7 citations) provides critical insights for clinical robustness. Collectively, his work has advanced the feasibility and precision of single-fraction, MR-guided brachytherapy, reducing treatment-related toxicity. Hautvast’s research is instrumental in bridging the gap between imaging technology and interventional oncology, offering a pathway to safer, more effective prostate cancer treatments.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3